The debate over 340B’s purpose recently spilled over into a Boston newspaper and nationally.
In a March 30 op-ed in the Boston Herald, Peter Pitts, a former U.S. Food and Drug Administration (FDA) official under President George W. Bush and drug industry consultant, said the program’s “original goal was to make brand-name drugs more affordable for uninsured and low-income populations.”
The debate over 340B’s purpose recently spilled over into a Boston newspaper and nationally.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
